Sarissa Capital Management
Latest statistics and disclosures from Sarissa Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IRWD, BIIB, INVA, GILD, NBIX, and represent 91.13% of Sarissa Capital Management's stock portfolio.
- Added to shares of these 3 stocks: CYTK (+$21M), GILD, BCRX.
- Started 1 new stock position in CYTK.
- Reduced shares in these 1 stock: NBIX (-$17M).
- Sarissa Capital Management was a net buyer of stock by $6.5M.
- Sarissa Capital Management has $572M in assets under management (AUM), dropping by -11.91%.
- Central Index Key (CIK): 0001577524
Tip: Access up to 7 years of quarterly data
Positions held by Sarissa Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 10 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 25.0 | $143M | 16M | 8.71 |
|
|
| Biogen Idec (BIIB) | 24.3 | $139M | 643k | 215.63 |
|
|
| Innoviva (INVA) | 19.4 | $111M | 7.3M | 15.24 |
|
|
| Gilead Sciences (GILD) | 14.1 | $81M | +2% | 1.1M | 73.25 |
|
| Neurocrine Biosciences (NBIX) | 8.4 | $48M | -26% | 346k | 137.92 |
|
| Amarin Corp Spons Adr New (AMRN) | 3.9 | $22M | 25M | 0.89 |
|
|
| Cytokinetics Com New (CYTK) | 3.7 | $21M | NEW | 300k | 70.11 |
|
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $5.6M | +9% | 1.1M | 5.08 |
|
| Vor Biopharma (VOR) | 0.3 | $1.5M | 618k | 2.37 |
|
|
| Regulus Therapeutics (RGLS) | 0.1 | $533k | 185k | 2.88 |
|
Past Filings by Sarissa Capital Management
SEC 13F filings are viewable for Sarissa Capital Management going back to 2013
- Sarissa Capital Management 2024 Q1 filed May 15, 2024
- Sarissa Capital Management 2023 Q4 filed Feb. 14, 2024
- Sarissa Capital Management 2023 Q3 filed Nov. 14, 2023
- Sarissa Capital Management 2023 Q2 filed Aug. 14, 2023
- Sarissa Capital Management 2023 Q1 filed May 15, 2023
- Sarissa Capital Management 2022 Q4 filed Feb. 14, 2023
- Sarissa Capital Management 2022 Q3 filed Nov. 14, 2022
- Sarissa Capital Management 2022 Q2 filed Aug. 15, 2022
- Sarissa Capital Management 2022 Q1 filed May 16, 2022
- Sarissa Capital Management 2021 Q4 filed Feb. 14, 2022
- Sarissa Capital Management 2021 Q3 filed Nov. 15, 2021
- Sarissa Capital Management 2021 Q2 filed Aug. 16, 2021
- Sarissa Capital Management 2021 Q1 filed May 17, 2021
- Sarissa Capital Management 2020 Q4 filed Feb. 16, 2021
- Sarissa Capital Management 2020 Q3 filed Nov. 16, 2020
- Sarissa Capital Management 2020 Q2 filed Aug. 14, 2020